Jennifer Ringler

Jim Currie and Baber Ghauri talk to Pharm Exec about making connections that resonate with audiences in a digital world.

Over 25 years the Rx Club Show has reflected dramatic technological changes in advertising. But, as always, the subject comes first, the medium second. So where did the accolades go this year?

The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal.

A Q&A with Andrew Webber, President and CEO of the National Business Coalition on Health

Novartis' Gilenya is a step forward in treating Multiple Sclerosis. But generating increased compliance is another story